Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-α

被引:15
作者
Kurokohchi, Kazutaka [1 ]
Takaguchi, Kouichi [2 ]
Kita, Keiji [2 ]
Masaki, Tsutomu [1 ]
Kuriyama, Shigeki [1 ]
机构
[1] Kagawa Univ Sch Med, Dept Internal Med 3, Miki, Kagawa 7610793, Japan
[2] Kagawa Prefectural Cent Hosp, Dept Internal Med, Kagawa 7608557, Japan
关键词
Hepatocellular carcinoma; 5-Fluorouracil; Pegylated interferon-alpha; Combination therapy;
D O I
10.3748/wjg.v11.i34.5401
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We report a case of hepatocellular carcinoma (HCC) treated successfully by transarterial chemoembolization (TACE) followed by combination therapy of 5-fluorouracil (5-FU) and pegylated interferon-alpha (PEG-IFN-alpha). In the present case, the patient had massive and advanced HCC with a diameter of over 8 cm located in segment 7 (S7) of the liver. Furthermore, the tumor invaded into the major branch of the portal vein (Vp3). After TACE, combined administration of 5-FU and PEG-IFN-alpha was performed for 5 mo. HCC was totally eradicated and the serum levels of tumor markers were markedly decreased by the treatment. Although it has been reported that the combined use of conventional IFN-alpha and 5-FU showed striking effects on HCC in some cases, this case may suggest the more promising effect of PEG-IFN-alpha with a long-lasting effect, in the combined use with 5-FU for the treatment of massive advanced HCC. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:5401 / 5403
页数:3
相关论文
共 8 条
[1]  
Chung YH, 2000, CANCER, V88, P1986, DOI 10.1002/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO
[2]  
2-I
[3]   Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis [J].
Kaneko, S ;
Urabe, T ;
Kobayashi, K .
ONCOLOGY, 2002, 62 :69-73
[4]  
Kurokohchi K, 2002, INT J ONCOL, V21, P611
[5]  
Kurokohchi K, 2002, INT J ONCOL, V21, P841
[6]  
Kurokohchi K, 2005, WORLD J GASTROENTERO, V11, P1426
[7]   Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma [J].
Patt, YZ ;
Hassan, MM ;
Lozano, RD ;
Brown, TD ;
Vauthey, JN ;
Curley, SA ;
Ellis, LM .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (03) :421-427
[8]   Combined Intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches [J].
Sakon, M ;
Nagano, H ;
Dono, K ;
Nakamori, S ;
Umeshita, K ;
Yamada, A ;
Kawata, S ;
Imai, Y ;
Iijima, S ;
Monden, M .
CANCER, 2002, 94 (02) :435-442